#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Skin cancer Malignant neoplasm of choroid Idiopathic inflammatory myopathy Canavan disease Liposarcoma recurrent Andersen-Tawil syndrome Neuroendocrine carcinoma Vascular calcification Osteosarcoma recurrent Ewing's sarcoma recurrent Anti-glomerular basement membrane disease KBG syndrome Chronic graft versus host disease in intestine Pemphigoid Osteopetrosis More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome – Diagnostics Richter’s syndrome – Life with Disease Pelizaeus-Merzbacher disease – Diagnostics Epidermolysis bullosa – Trials in Disease Von Willebrand’s disease – Basic Information Haemolytic uraemic syndrome – Basic Information Myelodysplastic syndrome – Basic Information Cystic fibrosis – Life with Disease Marfan’s syndrome – Treatment Piriformis syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Batoprotafib Mercaptopurine Revumenib Alx148 Eprosartan Mesilate Rucaparib Gallium (68Ga) DAPIGLUTIDE Ramipril Iron Sucrose Ddcart‐Cd19 Ofloxacin Hydrochloride Nadunolimab Emiplacel Loncastuximab Tesirine Betula Alba Pollen Extract Riociguat Vsf1.01 Caplacizumab Quercetin More therapies…

    Learn about Your Condition

    Corneal graft rejection Basal cell carcinoma Cystic fibrosis Malignant melanoma stage IV Urethral valves Chronic coronary syndrome Postpartum haemorrhage Langerhans' cell histiocytosis Arterial tortuosity syndrome Delirium Primary hypogonadism Malignant melanoma stage II Bronchostenosis Anorexia nervosa Insomnia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Teverelix for Patients with Advanced Prostate Cancer

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Teverelix
    Lithuania

  • Continued Access Study for Patients with Neurological Disease Using Ocrelizumab and Drug Combination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Nervous system disorder
    Investigated Drugs:
    • Ocrelizumab
    • Dexamethasone Acetate
    • Lidocaine Hydrochloride Monohydrate
    Czechia France Germany

  • Study on the Effectiveness of Trastuzumab, Pertuzumab, and Docetaxel for Patients with Early HER2-Positive Breast Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Pertuzumab
    Finland Sweden

  • Study on Heparin Sodium and Sodium Chloride for Patients with Lymphoma or Myeloma Undergoing Stem Cell Collection

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lymphoma
    • Plasma cell myeloma
    Investigated Drugs:
    • Heparin Sodium
    • Sodium Chloride
    Sweden

  • Study of tamsulosin and furosemide combination therapy for patients after shock wave lithotripsy of kidney stones

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephrolithiasis
    Investigated Drugs:
    • Furosemide
    • Tamsulosin Hydrochloride
    • Ibuprofen
    Denmark

  • Study of testosterone gel treatment for women with low ovarian reserve and androgen receptor polymorphism undergoing fertility treatment

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Follitropin Alfa
    • Ganirelix
    • Testosterone
    Spain
Previous Page
1 … 873 874 875 876 877 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!